CLDX · Celldex Therapeutics Inc.
View on chartInsiders & Stakes
| Marucci Anthony S PRESIDENT & CEO | ▲ Buy | Open Market | 40,284 Shares held | 11/11/2024 | View profile |
| Samuel Bates Martin SVP and CFO | ▲ Buy | Option Exercise | 32,942 Shares held | 1/2/2026 | View profile |
| Freddy A. Jimenez SVP & GENERAL COUNSEL | ▼ Sell | Open Market | 30,796 Shares held | 12/4/2025 | View profile |
| Richard M. Wright SR. VP & CCO | ▼ Sell | Open Market | 20,833 Shares held | 11/13/2025 | View profile |
| Ronald Pepin SR. VP & CBO | ▲ Buy | Option Exercise | 20,097 Shares held | 12/15/2025 | View profile |
| Young Diane C. SVP, Chief Medical Officer | ▲ Buy | Option Exercise | 17,115 Shares held | 6/11/2024 | View profile |
| Heath-Chiozzi Margo SVP of Regulatory Affairs | ▼ Sell | Open Market | 13,383 Shares held | 6/3/2024 | View profile |
| Crowley Elizabeth Sr. VP &CPDO | ▼ Sell | Open Market | 9,074 Shares held | 6/14/2024 | View profile |
| KELER TIBOR EXECUTIVE VP & CSO | ▼ Sell | Open Market | 7,357 Shares held | 12/7/2022 | View profile |
| MARINO JAMES J Director | ▼ Sell | Gift | 2,204 Shares held | 11/18/2024 | View profile |
| Cavanaugh Sarah SVP of Corp Affairs & Admin. | ▼ Sell | Open Market | 1,860 Shares held | 5/30/2024 | View profile |
Transaction History
| Samuel Bates Martin | ▲ Buy | Option Exercise | 4,817 | $50K | 1/2/2026 |
| Ronald Pepin | ▲ Buy | Option Exercise | 8,333 | $75K | 12/15/2025 |
| Ronald Pepin | ▲ Buy | Option Exercise | 11,000 | $31K | 12/15/2025 |
| Freddy A. Jimenez | ▼ Sell | Open Market | 4,166 | $121K | 12/4/2025 |
| Richard M. Wright | ▲ Buy | Option Exercise | 6,876 | $62K | 11/13/2025 |
| Richard M. Wright | ▲ Buy | Option Exercise | 26,672 | $277K | 11/13/2025 |
| Richard M. Wright | ▲ Buy | Option Exercise | 15,750 | $354K | 11/13/2025 |
| Richard M. Wright | ▼ Sell | Open Market | 49,298 | $1.2M | 11/13/2025 |
| Freddy A. Jimenez | ▼ Sell | Open Market | 341 | $8K | 8/13/2025 |
| Freddy A. Jimenez | ▼ Sell | Open Market | 430 | $11K | 8/13/2025 |
| MARINO JAMES J | ▼ Sell | Gift | 10,500 | $0 | 11/18/2024 |
| Marucci Anthony S | ▲ Buy | Open Market | 11,500 | $308K | 11/11/2024 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 3,201 | $29K | 6/14/2024 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 16,968 | $176K | 6/14/2024 |
| Samuel Bates Martin | ▼ Sell | Open Market | 17,172 | $608K | 6/14/2024 |
| Crowley Elizabeth | ▲ Buy | Option Exercise | 30,000 | $311K | 6/14/2024 |
| Crowley Elizabeth | ▼ Sell | Open Market | 30,000 | $1.0M | 6/14/2024 |
| Young Diane C. | ▲ Buy | Option Exercise | 15,000 | $41K | 6/11/2024 |
| Crowley Elizabeth | ▲ Buy | Option Exercise | 7,500 | $78K | 6/7/2024 |
| Crowley Elizabeth | ▲ Buy | Option Exercise | 7,500 | $68K | 6/7/2024 |
| Crowley Elizabeth | ▼ Sell | Open Market | 15,000 | $526K | 6/7/2024 |
| Young Diane C. | ▼ Sell | Open Market | 45,000 | $1.6M | 6/7/2024 |
| Freddy A. Jimenez | ▲ Buy | Option Exercise | 9,540 | $99K | 6/5/2024 |
| Heath-Chiozzi Margo | ▲ Buy | Option Exercise | 6,289 | $57K | 6/3/2024 |
| Heath-Chiozzi Margo | ▲ Buy | Option Exercise | 58,369 | $606K | 6/3/2024 |
| Richard M. Wright | ▲ Buy | Option Exercise | 20,625 | $57K | 6/3/2024 |
| Richard M. Wright | ▲ Buy | Option Exercise | 28,469 | $797K | 6/3/2024 |
| Richard M. Wright | ▲ Buy | Option Exercise | 18,375 | $413K | 6/3/2024 |
| Richard M. Wright | ▼ Sell | Open Market | 27,580 | $925K | 6/3/2024 |
| Richard M. Wright | ▼ Sell | Open Market | 19,264 | $655K | 6/3/2024 |
| Freddy A. Jimenez | ▲ Buy | Option Exercise | 8,006 | $83K | 6/3/2024 |
| Freddy A. Jimenez | ▼ Sell | Open Market | 8,006 | $269K | 6/3/2024 |
| Heath-Chiozzi Margo | ▼ Sell | Open Market | 58,369 | $2.0M | 6/3/2024 |
| Cavanaugh Sarah | ▼ Sell | Open Market | 20,853 | $703K | 5/30/2024 |
| Heath-Chiozzi Margo | ▲ Buy | Option Exercise | 29,068 | $81K | 5/30/2024 |
| Heath-Chiozzi Margo | ▲ Buy | Option Exercise | 2,043 | $18K | 5/30/2024 |
| Heath-Chiozzi Margo | ▲ Buy | Option Exercise | 2,608 | $27K | 5/30/2024 |
| Heath-Chiozzi Margo | ▼ Sell | Open Market | 38,719 | $1.3M | 5/30/2024 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 25,000 | $260K | 5/30/2024 |
| Samuel Bates Martin | ▼ Sell | Open Market | 35,000 | $1.2M | 5/30/2024 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 10,750 | $30K | 5/30/2024 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 10,103 | $91K | 5/30/2024 |
| Crowley Elizabeth | ▲ Buy | Option Exercise | 34,445 | $96K | 5/30/2024 |
| Crowley Elizabeth | ▲ Buy | Option Exercise | 8,500 | $77K | 5/30/2024 |
| Crowley Elizabeth | ▼ Sell | Open Market | 38,597 | $1.3M | 5/30/2024 |
| Freddy A. Jimenez | ▲ Buy | Option Exercise | 4,166 | $38K | 2/13/2024 |
| Freddy A. Jimenez | ▲ Buy | Option Exercise | 20,000 | $56K | 2/13/2024 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 10,750 | $30K | 1/2/2024 |
| KELER TIBOR | ▲ Buy | Option Exercise | 16,860 | $47K | 12/7/2022 |
| KELER TIBOR | ▼ Sell | Open Market | 16,860 | $623K | 12/7/2022 |
| Cavanaugh Sarah | ▼ Sell | Open Market | 1,355 | $49K | 8/18/2022 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 1,355 | $12K | 8/18/2022 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 31,312 | $87K | 8/17/2022 |
| Cavanaugh Sarah | ▼ Sell | Open Market | 31,312 | $1.2M | 8/17/2022 |
| Young Diane C. | ▲ Buy | Option Exercise | 19,000 | $197K | 8/17/2022 |
| Young Diane C. | ▼ Sell | Open Market | 19,000 | $709K | 8/17/2022 |
| Young Diane C. | ▲ Buy | Option Exercise | 45,000 | $122K | 8/17/2022 |
| Marucci Anthony S | ▲ Buy | Option Exercise | 75,000 | $208K | 8/15/2022 |
| Marucci Anthony S | ▲ Buy | Option Exercise | 45,000 | $406K | 8/15/2022 |
| Marucci Anthony S | ▼ Sell | Open Market | 120,000 | $4.5M | 8/15/2022 |
| Richard M. Wright | ▲ Buy | Option Exercise | 15,328 | $159K | 8/15/2022 |
| Richard M. Wright | ▼ Sell | Open Market | 15,328 | $578K | 8/15/2022 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 3,876 | $35K | 8/12/2022 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 13,671 | $38K | 8/12/2022 |
| Samuel Bates Martin | ▼ Sell | Open Market | 14,261 | $524K | 8/12/2022 |
| Samuel Bates Martin | ▼ Sell | Open Market | 2,065 | $73K | 8/12/2022 |
| Samuel Bates Martin | ▼ Sell | Open Market | 1,221 | $42K | 8/12/2022 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 2,453 | $22K | 8/11/2022 |
| Samuel Bates Martin | ▼ Sell | Open Market | 2,453 | $91K | 8/11/2022 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 3,250 | $29K | 12/23/2021 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 3,750 | $10K | 12/23/2021 |
| Samuel Bates Martin | ▼ Sell | Open Market | 9,500 | $399K | 12/23/2021 |
| Heath-Chiozzi Margo | ▲ Buy | Option Exercise | 600 | $2K | 12/8/2021 |
| Crowley Elizabeth | ▼ Sell | Open Market | 4,000 | $160K | 12/8/2021 |
| Heath-Chiozzi Margo | ▼ Sell | Open Market | 600 | $24K | 12/8/2021 |
| Crowley Elizabeth | ▲ Buy | Option Exercise | 4,000 | $36K | 12/8/2021 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 1,857 | $17K | 12/8/2021 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 5,466 | $57K | 12/8/2021 |
| Cavanaugh Sarah | ▼ Sell | Open Market | 7,323 | $293K | 12/8/2021 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 3,750 | $10K | 11/15/2021 |
| Samuel Bates Martin | ▼ Sell | Open Market | 2,048 | $87K | 11/15/2021 |
| Samuel Bates Martin | ▼ Sell | Open Market | 7,452 | $327K | 11/15/2021 |
| Samuel Bates Martin | ▲ Buy | Option Exercise | 3,250 | $29K | 11/15/2021 |
| Young Diane C. | ▲ Buy | Option Exercise | 4,600 | $48K | 11/12/2021 |
| Young Diane C. | ▼ Sell | Open Market | 4,600 | $198K | 11/12/2021 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 5,018 | $45K | 11/1/2021 |
| Cavanaugh Sarah | ▲ Buy | Option Exercise | 938 | $3K | 11/1/2021 |
| Cavanaugh Sarah | ▼ Sell | Open Market | 4,302 | $190K | 11/1/2021 |
| Cavanaugh Sarah | ▼ Sell | Open Market | 901 | $39K | 11/1/2021 |
| Cavanaugh Sarah | ▼ Sell | Open Market | 2,120 | $88K | 11/1/2021 |
| Crowley Elizabeth | ▲ Buy | Option Exercise | 8,555 | $24K | 11/1/2021 |
| Crowley Elizabeth | ▼ Sell | Open Market | 2,528 | $112K | 11/1/2021 |
| Crowley Elizabeth | ▼ Sell | Open Market | 600 | $26K | 11/1/2021 |
| Crowley Elizabeth | ▼ Sell | Open Market | 1,189 | $49K | 11/1/2021 |
| Heath-Chiozzi Margo | ▲ Buy | Option Exercise | 600 | $2K | 11/1/2021 |
| Heath-Chiozzi Margo | ▼ Sell | Open Market | 600 | $25K | 11/1/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 24, 2026
Celldex shares dip after positive Phase 3 barzolvolimab results
Celldex reported that its drug barzolvolimab met endpoints in Phase 3 trials for chronic spontaneous urticaria, showing durable responses. Despite these positive results, the stock fell 11%, with some analysts noting that safety concerns appear misplaced. Major firms like Morgan Stanley and Leerink Partners recently raised their price targets, while the company continues to manage a high cash burn rate.
Celldex shares dip after positive Phase 3 barzolvolimab results. Celldex reported that its drug barzolvolimab met endpoints in Phase 3 trials for chronic spontaneous urticaria, showing durable responses. Despite these positive results, the stock fell 11%, with some analysts noting that safety concerns appear misplaced. Major firms like Morgan Stanley and Leerink Partners recently raised their price targets, while the company continues to manage a high cash burn rate.